Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Atlas Arteria ( (AU:ALX) ) has shared an announcement.
Atlas Arteria announced a change in the director’s interest, with Hugh Wehby acquiring 654,884 Performance Rights under the company’s Long Term Incentive Plan. This move, approved at the 2025 AGM, reflects the company’s commitment to aligning its leadership’s interests with long-term strategic goals, potentially impacting its market positioning and stakeholder confidence.
The most recent analyst rating on (AU:ALX) stock is a Hold with a A$5.66 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a company operating in the infrastructure sector, focusing on managing and developing toll roads globally. The company is known for its investments in major road networks, providing essential transportation infrastructure.
Average Trading Volume: 2,307,031
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$7.65B
For detailed information about ALX stock, go to TipRanks’ Stock Analysis page.